• No results found

<p>Reported light in the sleep environment: enhancement of the sleep diary</p>

N/A
N/A
Protected

Academic year: 2020

Share "<p>Reported light in the sleep environment: enhancement of the sleep diary</p>"

Copied!
16
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1 Representation of photoreceptor thresholds, visual responses, and their relationship to the range of illumination from natural and artificial light sources.Notes: This schematic illustrates estimated levels of visual stimulation for typical ambien
Figure 2 Actigram from a participant working day shifts (7 am–7 pm).Notes: Time is represented from noon to noon on the x-axis, with days represented on the y-axis
Figure 3 Flowchart of response frequencies for the four light questions at BT and WT.Notes: Bolded text is used for questions and unbolded text for responses
Table 1 Reported light and photopic illumination (TA10)
+7

References

Related documents

Changes in gross margins (in %) due to the cumulative impacts of climate change, adaptation, price and policy changes, and technological development for the A1/W+ and B2/G

The provision contained one express exception: if the migrant worker was employed in France, while his family continued to live in another Member State, the

Serologically Confirmed GAS Culture–Positive Pharyngitis Nineteen primary episodes were unequivocal GAS phar- yngitis, and 16 episodes were likely serologically con- firmed

Search terms used included the following: (((penile cancer) or (penile tumor) or (penile neoplasm) or (penile squamous cell carcinoma))) AND ((inguinal lymph node metastasis) or

To mitigate the need for performing verifications for each dynamic operation on the outsourced data, in our solution both the client and the server maintain metadata in the form of

For this reason, our objective has been to improve the sample preparation process and to develop an economic, rapid, and sensitive HPLC method for

The main objective of our study was to compare the effects of nepafenac ophthalmic suspension 0.1% (Nevanac; Alcon, Tokyo, Japan) and diclofenac sodium ophthalmic